Abstract
Variants in RCBTB1 have been implicated in inherited retinal disease (IRD). Here, we generated induced pluripotent stem cells (iPSCs) from a 45-year-old female IRD patient harbouring compound heterozygous mutations in the RCBTB1 gene. Episomal plasmids containing OCT4, SOX2, KLF4, MYCL, LIN28, shRNA for TP53 and mir302/367 microRNA were employed to conduct the reprogramming of primary dermal fibroblasts. These iPSC lines provide a useful model for further investigations on the pathophysiological role of mutations in the RCBTB1 gene in IRD.
Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Cell Differentiation
-
Cell Line / cytology*
-
Cell Line / metabolism
-
Cells, Cultured
-
Female
-
Fibroblasts / cytology
-
Fibroblasts / metabolism
-
Frameshift Mutation
-
Guanine Nucleotide Exchange Factors / genetics*
-
Guanine Nucleotide Exchange Factors / metabolism
-
Humans
-
Induced Pluripotent Stem Cells / cytology*
-
Induced Pluripotent Stem Cells / metabolism
-
Kruppel-Like Factor 4
-
Kruppel-Like Transcription Factors / genetics
-
Kruppel-Like Transcription Factors / metabolism
-
Middle Aged
-
Octamer Transcription Factor-3 / genetics
-
Octamer Transcription Factor-3 / metabolism
-
Retinal Dystrophies / genetics*
-
Retinal Dystrophies / metabolism
-
Retinal Dystrophies / physiopathology
-
SOXB1 Transcription Factors / genetics
-
SOXB1 Transcription Factors / metabolism
Substances
-
Guanine Nucleotide Exchange Factors
-
KLF4 protein, human
-
Kruppel-Like Factor 4
-
Kruppel-Like Transcription Factors
-
Octamer Transcription Factor-3
-
POU5F1 protein, human
-
RCBTB1 protein, human
-
SOX2 protein, human
-
SOXB1 Transcription Factors